RIG
35
-3
NEE
52
-2
VRTX
56
-4
ICE
64
-5
D
55
-6
ABT
57
-9
GT
46
3
SO
64
-2
JBHT
49
3
TXT
58
-2
HRL
38
2
VZ
45
-2
MA
65
-4
UHS
58
4
HSY
38
-2
SPG
53
-2
JNJ
51
-2
LEG
29
4
INTC
37
-4
SWN
70
3
RIG
35
-3
NEE
52
-2
VRTX
56
-4
ICE
64
-5
D
55
-6
ABT
57
-9
GT
46
3
SO
64
-2
JBHT
49
3
TXT
58
-2
HRL
38
2
VZ
45
-2
MA
65
-4
UHS
58
4
HSY
38
-2
SPG
53
-2
JNJ
51
-2
LEG
29
4
INTC
37
-4
SWN
70
3
Financhill
Back

BridgeBio Pharma Quote, Financials, Valuation and Earnings

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager
Sell
39

BBIO
BridgeBio Pharma

Last Price:
26.81
Seasonality Move:
21.04%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

BridgeBio Pharma Price Quote

$26.81
+0.85 (+3.27%)
(Updated: September 19, 2024 at 5:45 PM ET)

BridgeBio Pharma Key Stats

Sell
39
BridgeBio Pharma (BBIO) is a Sell
Day range:
$25.80 - $26.84
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.85
P/B ratio:
0%
Volume:
1.5M
Avg. volume:
2.2M
1-year change:
-9.04%
Market cap:
$4.9B
Revenue:
$9.3M
EPS:
$-2.63

How Much Does BridgeBio Pharma Make?

Is BridgeBio Pharma Growing As A Company?

  • What Is BridgeBio Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.32%
  • What Is BridgeBio Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BridgeBio Pharma Stock Price Performance

  • Did BridgeBio Pharma Stock Go Up Last Month?
    BridgeBio Pharma share price went up by 6.39% last month
  • Did BBIO's Share Price Rise Over The Last Year?
    BBIO share price fell by -9.04% over the past 1 year

What Is BridgeBio Pharma 52-Week High & Low?

BridgeBio Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BridgeBio Pharma?

  • How Much Debt Does BridgeBio Pharma Have?
    Total long term debt quarterly is $1.7B
  • How Much Cash Does BridgeBio Pharma Have?
    Cash and short term investments quarterly total is $447.8M
  • What Is BridgeBio Pharma’s Book Value Per Share?
    Book value per share is -5.81

Is BridgeBio Pharma Cash Flow Positive?

  • What Is BBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$414.9M
  • What Is BridgeBio Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $576.3M
  • What Is BridgeBio Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $63.4M

BridgeBio Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    BBIO return on invested capital is -87.43%
  • What Is BridgeBio Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -67.76%
  • What Is BBIO Return On Equity?
    ROE is a measure of profitability and is 0%

BridgeBio Pharma Earnings Date & Stock Price

BridgeBio Pharma Competitors

  • Who Are BridgeBio Pharma's Competitors?
    Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
    • Agios Pharmaceuticals Inc (AGIO)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Ionis Pharmaceuticals Inc (IONS)
    • MediciNova Inc (MNOV)
    • Pfizer Inc (PFE)

BridgeBio Pharma Dividend Yield

BridgeBio Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.24%
Revenue: 32.12% -51.55%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 48.07
Upside from Last Price: 85.18%

Major Shareholders

  • How many BBIO shares are owned by institutional investors?
    219.1M BBIO shares are owned by institutional investors
  • How many BBIO shares are owned by insiders?
    7.3M BBIO shares are owned by insiders